We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merz Tops Valeant With $383M Bid For Obagi

Law360, New York (April 2, 2013, 3:03 PM EDT) -- German drugmaker Merz Pharma Group on Tuesday launched a $383.5 million acquisition offer for California-based cosmetics company Obagi Medical Products Inc., topping a $344 million proposal from Valeant Pharmaceuticals International Inc....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.